Giovanni Ostuzzi (G Ostuzzi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Hyaluronic Acid

Top Venues

Epidemiology and psychiatric sciences

Therapeutic advances in psychopharmacology

The British journal of surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Corrado Pedrazzani, Giulia Turri, Giovanni Ostuzzi, Corrado Barbui
Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials. The British journal of surgery 111 (8) (2024)
Giovanni Vita, Angelantonio Tavella, Giovanni Ostuzzi, Federico Tedeschi, Michele De Prisco, Rafael Segarra, Marco Solmi, Corrado Barbui, Christoph U Correll
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology 14 (2024)
Corrado Barbui, Davide Papola, Beatrice Todesco, Chiara Gastaldon, Giovanni Ostuzzi
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries. Epidemiology and psychiatric sciences 33 (2024)
Corrado Barbui, Davide Papola, Beatrice Todesco, Chiara Gastaldon, Giovanni Ostuzzi
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries. Epidemiology and psychiatric sciences 33 (2024)
Corrado Pedrazzani, Giulia Turri, Giovanni Ostuzzi, Corrado Barbui
Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials. The British journal of surgery 111 (8) (2024)
Corrado Barbui, Davide Papola, Beatrice Todesco, Chiara Gastaldon, Giovanni Ostuzzi
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries. Epidemiology and psychiatric sciences 33 (2024)
Giovanni Vita, Angelantonio Tavella, Giovanni Ostuzzi, Federico Tedeschi, Michele De Prisco, Rafael Segarra, Marco Solmi, Corrado Barbui, Christoph U Correll
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology 14 (2024)
Giovanni Ostuzzi, Federico Tedeschi, Federico Bertolini, Carlo Cotugno, Andrea Aguglia, Francesco Bartoli, Giuseppe Carrà, Armando D'Agostino, Giovanni Martinotti, Corrado Barbui, Chiara Gastaldon, Davide Papola
Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
Giovanni Ostuzzi, Johannes Schneider-Thoma, Federico Tedeschi, Stefan Leucht, Corrado Barbui
Crossroads of methodological choices in research synthesis: insights from two network meta-analyses on preventing relapse in schizophrenia. BMJ mental health 26 (1) (2023)
Chiara Gastaldon, Elena Arzenton, Emanuel Raschi, Olav Spigset, Davide Papola, Giovanni Ostuzzi, Ugo Moretti, G Trifirò, Corrado Barbui, Georgios Schoretsanitis
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database. Psychological medicine (2022)
Giovanni Ostuzzi, Chiara Gastaldon, Davide Papola, Corrado Barbui
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries. Epidemiology and psychiatric sciences 31 (2022)
Beatrice Todesco, Giovanni Ostuzzi, Corrado Barbui
Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level. Epidemiology and psychiatric sciences 31 (2022)
Francesco Bartoli, Tommaso Callovini, Francesco Bartoli, Cristina Crocamo, Ilaria Riboldi, Andrea Aguglia, Cristina Segura-Garcia, Giovanni Martinotti, Armando D'Agostino, Giovanni Ostuzzi, Corrado Barbui, Giuseppe Carrà, null null
Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study. European archives of psychiatry and clinical neuroscience (2022)
Giovanni Ostuzzi, Davide Papola, Chiara Gastaldon, Georgios Schoretsanitis, Federico Bertolini, Francesco Amaddeo, Alessandro Cuomo, Robin Emsley, Andrea Fagiolini, Giuseppe Imperadore, Taishiro Kishimoto, Giulia Michencigh, Michela Nosé, Marianna Purgato, Serdar Dursun, Brendon Stubbs, David Taylor, Graham Thornicroft, Philip B Ward, Christoph Hiemke, Christoph U Correll, Corrado Barbui
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations. BMC medicine 18 (1) (2020)
Corrado Barbui, Federico Bertolini, Francesco Bartoli, Carmela Calandra, Camilla Callegari, Giuseppe Carrà, Armando D'Agostino, Claudio Lucii, Giovanni Martinotti, Daniele Mastromo, Daniele Moretti, Emiliano Monzani, Matteo Porcellana, Davide Prestia, Giovanni Ostuzzi, null null
Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study. Therapeutic advances in psychopharmacology 10 (2020)
Chiara Gastaldon, D Papola, Giovanni Ostuzzi, Corrado Barbui
Esketamine clinical trials: reply to Maju et al. Epidemiology and psychiatric sciences 29 (2020)
Giovanni Ostuzzi, Chiara Gastaldon, Carlo Petrini, Brian Godman, Corrado Barbui
Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries. Epidemiology and psychiatric sciences 29 (2020)
Giovanni Ostuzzi, Chiara Gastaldon, Davide Papola, Andrea Fagiolini, Serdar Dursun, David M Taylor, Christoph U Correll, Corrado Barbui
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches. Therapeutic advances in psychopharmacology 10 (2020)
Davide Papola, Giovanni Ostuzzi, C Gastaldon, G P Morgano, E Dragioti, A F Carvalho, P Fusar-Poli, Christoph U Correll, Marco Solmi, C Barbui
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies. Acta psychiatrica Scandinavica 140 (3) (2019)
Giovanni Ostuzzi, Maria Angela Mazzi, Samira Terlizzi, Federico Bertolini, Andrea Aguglia, Francesco Bartoli, Paola Bortolaso, Camilla Callegari, Mariarita Caroleo, Giuseppe Carrà, Mariangela Corbo, Armando D'Agostino, Chiara Gastaldon, Claudio Lucii, Fabio Magliocco, Giovanni Martinotti, Michela Nosé, Edoardo Giuseppe Ostinelli, Davide Papola, Marco Piero Piccinelli, Alberto Piccoli, Marianna Purgato, Tommaso Tabacchi, Giulia Turrini, Mirella Ruggeri, Corrado Barbui, null null
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy. PloS one 13 (8) (2018)
Giovanni Ostuzzi, Corrado Barbui, Charlotte Hanlon, Sudipto Chatterjee, Julian Eaton, Lynne Jones, Derrick Silove, Peter Ventevogel
Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance. BMC medicine 15 (1) (2017)